Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease

OBJECTIVE: Widespread implementation of cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non‐AD dementias. Novel and promising CSF biomarkers include neurogranin, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Janelidze, Shorena, Hertze, Joakim, Zetterberg, Henrik, Landqvist Waldö, Maria, Santillo, Alexander, Blennow, Kaj, Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704480/
https://www.ncbi.nlm.nih.gov/pubmed/26783546
http://dx.doi.org/10.1002/acn3.266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704480/
https://www.ncbi.nlm.nih.gov/pubmed/26783546
http://dx.doi.org/10.1002/acn3.266

Ejemplares similares